查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1974092

細胞培養基袋市場：依產品類型、細胞類型、包裝形式和應用分類－全球預測，2026-2032年

Cell Culture Media Bags Market by Product Type, Cell Type, Packaging Mode, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，細胞培養基袋市場價值將達到 13.2 億美元，到 2026 年將成長至 14.3 億美元，到 2032 年將達到 25.3 億美元，複合年成長率為 9.67%。

主要市場統計數據
基準年 2025 13.2億美元
預計年份：2026年 14.3億美元
預測年份：2032年 25.3億美元
複合年成長率 (%) 9.67%

簡潔且權威的介紹，概述了重組細胞培養基袋的選擇和採用的運作和技術促進因素。

細胞培養基袋領域正處於生物製程創新、一次性技術應用和不斷變化的監管要求的交匯點。近年來，培養基袋設計、材料相容性和無菌保證方面的技術進步，以及對靈活生物製造平台日益成長的需求，共同為研發人員和終端用戶創造了一個充滿活力的環境。本報告的執行層面概述對影響現代細胞培養工作流程中產品選擇、適用性和供應鏈策略的關鍵營運、技術和商業因素進行了全面分析。

技術進步和更嚴格的法規如何共同改變人們對一次性培養基供應系統的採購、驗證和夥伴關係的預期？

過去幾年，細胞培養基供應格局發生了翻天覆地的變化，這主要得益於跨領域的創新和用戶需求的不斷變化。一次性聚合物技術的進步提高了材料的性能和相容性，使其在敏感的哺乳動物細胞和昆蟲細胞應用中得到更廣泛的應用。同時，隨著封閉式系統工作流程的日益成熟，能夠支持無菌轉移、最大限度減少頂部空間氧氣暴露以及與上下游設備可靠連接的培養袋設計的重要性也日益凸顯。

近期關稅調整對生物製造耗材籌資策略、供應連續性和本地合格選擇的實際影響。

2025年實施的新關稅措施為細胞培養基袋的全球採購和供應商選擇策略帶來了新的複雜性。關稅調整改變了進口聚合物組件和一次性成品組件的相對經濟效益，促使企業重新評估供應商的選址和物流模式。為此，許多採購團隊開始進行情境規劃，以了解諸如到岸成本波動、前置作業時間延長以及潛在的供應商整合等營運影響。

可操作的細分主導洞察，將產品類型、應用重點、細胞譜系和包裝模式與採購和驗證優先事項連結起來。

為了使產品開發和採購重點與最終用戶需求保持一致，清晰了解產品和應用細分至關重要。依產品類型分類，市場分為2D培養袋和3D培養袋，前者是針對傳統平面製程最佳化的設備，後者是專為高容量培養或骨架培養而設計的設備。按應用分類，市場分為生物製藥生產和研發兩大領域。生物製藥生產領域進一步細分為單株抗體生產、重組蛋白生產和疫苗生產。研發領域則分為生物製程開發、單株抗體研究和幹細胞研究。這種細分方式闡明了最終用戶如何根據製程階段優先考慮無菌保證、可擴展性和材料相容性等屬性。

區域趨勢和監管差異是影響全球生物製造地供應商選擇、庫存策略和業務永續營運的關鍵因素。

在細胞培養基袋領域，區域因素持續影響策略重點、供應商選擇和法規遵循。在美洲，對先進生物製藥開發和契約製造的投資推動了對檢驗且可擴展的一次性使用系統的需求。該地區的企業往往優先考慮快速臨床部署和一體化的供應商服務。同時，在歐洲、中東和非洲，複雜的法規環境以及對合規文件和標準化品質系統的高度重視，促使供應商提供先進的技術文件和特定區域的法規支援。

供應商的透明度、材料專業知識和整合服務模式，在一次性培養基供應解決方案中創造了競爭優勢。

細胞培養基袋生態系統中的領先供應商透過技術文件、材料科學專業知識和整合服務的組合來脫穎而出。投資於全面的提取和洗脫測試、一致性矩陣以及強大的供應鏈可追溯性的公司，在與受監管的製造商和合約組織合作時，能夠獲得明顯的優勢。這些能力減輕了客戶下游驗證的負擔，並支援在生產關鍵應用中的快速部署。

為培養基供應系統的使用者提供實用有效的建議，以增強供應商的韌性，提高驗證效率，並提高營運靈活性。

產業領導者應採取切實可行的方案，在提升即時營運韌性的同時，兼顧策略能力建構。首先，應優先考慮在不同地區建立多元化的認證供應商網路，以降低單一故障點所帶來的風險。使供應商認證時間表與區域監管要求保持一致，將有助於加快並行採購流程，避免返工。其次，應投入資源進行深入的技術實質審查，重點關注萃取物/浸出液特性、材料相容性和連接器互通性，以最大程度地減少製程轉型和規模化生產過程中可能出現的意外問題。

我們嚴謹的混合方法研究途徑，結合技術訪談、材料評估和供應商文件的交叉檢驗，為實際決策提供支援。

本報告的調查方法結合了對技術和採購經理的訪談、對材料科學文獻的全面回顧以及對供應商技術文件的交叉檢驗，以確保研究結果的可靠性。主要資料收集工作包括對製程開發科學家、品質保證經理和採購專家進行結構化訪談，以了解與容器選擇和認證相關的實際限制和優先事項。此外，還對公開的技術報告和監管指導文件進行了詳細分析，以檢驗檢驗和文件記錄實踐，從而補充了這些定性證據。

主要結論強調了技術檢驗在決策、供應商透明度和供應鏈韌性方面的綜合重要性。

總而言之，包裝袋設計、材料科學和監管要求的進步正在重塑組織選擇和認證培養基供應系統的方式。如今，技術性能、文件嚴謹性和供應鏈配置的相互作用與產品規格一樣，都對營運準備就緒起著決定性作用。因此，採購決策需要從全面觀點出發，包括合規性測試、供應商透明度、區域認證要求和緊急時應對計畫。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 細胞培養基袋市場：依產品類型分類

  • 2D包
  • 3D袋

第9章：細胞培養基袋市場：依細胞類型分類

  • 昆蟲
  • 哺乳動物
    • CHO
    • 融合瘤
    • NS0

第10章 細胞培養基袋市場：依包裝類型分類

  • 散裝袋
  • 一次性預填充裝袋

第11章：細胞培養基袋市場：依應用分類

  • 生物製藥生產
    • 單株抗體生產
    • 重組蛋白生產
    • 疫苗生產
  • 研究與開發
    • 生物製程開發
    • 單株抗體研究
    • 幹細胞研究

第12章 細胞培養基袋市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 細胞培養基袋市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 細胞培養基袋市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國細胞培養基袋市場

第16章：中國細胞培養基袋市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avantor, Inc.
  • BIOPAC
  • CellBios Healthcare & Lifesciences Pvt Ltd
  • Corning Incorporated
  • Danaher Corporation
  • Entegris, Inc.
  • Eppendorf AG
  • FUJIMORI KOGYO Co., Ltd.
  • Greiner Bio-One International GmbH
  • Lonza Group AG
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • OriGen Biomedical, Inc.
  • Parker Hannifin Corporation
  • PBS BIoTech, LLC
  • Repligen Corporation
  • Saint-Gobain Life Sciences
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.
  • Tofflon Life Science Co., Ltd.
Product Code: MRR-5D340F440B75

The Cell Culture Media Bags Market was valued at USD 1.32 billion in 2025 and is projected to grow to USD 1.43 billion in 2026, with a CAGR of 9.67%, reaching USD 2.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.32 billion
Estimated Year [2026] USD 1.43 billion
Forecast Year [2032] USD 2.53 billion
CAGR (%) 9.67%

A concise authoritative introduction that frames the operational and technological drivers reshaping selection and adoption of cell culture media bags

The cell culture media bags sector is at the intersection of bioprocess innovation, single-use technology adoption, and evolving regulatory expectations. Recent technological refinements in bag design, materials compatibility, and sterility assurance have converged with heightened demand for flexible biomanufacturing platforms to create a dynamic environment for developers and end users alike. This report's executive-level overview synthesizes the key operational, technological, and commercial forces influencing product selection, application suitability, and supply chain strategies in contemporary cell culture workflows.

Stakeholders across biopharmaceutical production and research organizations are navigating a landscape that rewards nimble supply arrangements and validated single-use solutions. As organizations increasingly prioritize speed to clinic, product quality, and process reproducibility, packaging and handling considerations have gained prominence alongside standard performance metrics. The introduction of more complex cell formats and higher-value biologics places exacting demands on media delivery systems, driving attention to compatibility, extractables and leachables profiles, and closed-system integration.

The summary that follows distills these multifaceted dynamics into actionable insights for leaders seeking to align procurement, development, and manufacturing strategies with emerging best practices. Throughout, emphasis is placed on practical implications for product selection and operational adaptation rather than abstract projections, enabling decision-makers to identify priorities for immediate and medium-term initiatives.

How technological advances and regulatory rigor are jointly rewriting procurement, validation, and partnership expectations for single-use media delivery systems

Over the past several years, the environment for cell culture media delivery has undergone transformative shifts driven by cross-cutting innovations and changing user expectations. Advances in single-use polymer technologies have improved material performance and compatibility, enabling broader acceptance across sensitive mammalian and insect cell applications. At the same time, the maturation of closed-system workflows has elevated the importance of bag design that supports aseptic transfer, minimal headspace oxygen exposure, and reliable connectivity to upstream and downstream equipment.

Procurement and manufacturing groups have responded to these engineering improvements by prioritizing supplier collaboration and enhanced documentation to expedite validation programs. Regulatory agencies have also increased scrutiny on component qualification and extractables/leachables characterization, prompting vendors to invest in more rigorous testing protocols and clearer technical dossiers. Concurrently, end users are seeking modular and scalable solutions that permit rapid scale-up without compromising reproducibility or contaminant control.

These transformative shifts have altered how organizations evaluate value: product durability and upfront cost are being balanced against lifecycle risk, operational flexibility, and time-to-deliverables. As processes become more complex, interoperability and supplier transparency have emerged as non-negotiable attributes. Decisions are increasingly informed by direct compatibility data, real-world user validation, and risk-based approaches to component selection, which together are recalibrating procurement criteria and partnership models.

Practical implications of recent tariff adjustments on sourcing strategies, supply continuity, and local qualification choices for biomanufacturing consumables

The introduction of new tariff measures in 2025 has introduced tangible complexity into global sourcing and vendor selection strategies for cell culture media bags. Tariff adjustments have altered the comparative economics of importing polymer components and finished single-use assemblies, encouraging organizations to re-evaluate supplier footprints and logistics models. In response, many procurement teams have initiated scenario planning to understand the operational implications of shifted landed costs, longer lead times, and potential supplier consolidation.

Beyond immediate cost considerations, tariffs affect decisions about where to qualify suppliers and how to structure multi-supplier strategies. Organizations that previously optimized around lowest unit cost are shifting focus toward supply chain resilience, local regulatory alignment, and reduced cross-border dependencies. This recalibration is influencing both long-term sourcing and near-term inventory practices, as buyers weigh holding additional safety stock against the operational costs of extended storage and material shelf-life constraints.

Tariff-driven changes are also accelerating partnerships with regional contract manufacturers and packaging specialists who can provide shorter lead times and localized regulatory support. Such collaborations support faster qualification cycles and mitigate exposure to customs-related delays. From a strategic standpoint, firms that proactively reassess supplier risk, diversify sourcing channels, and engage in collaborative cost-management negotiations are better positioned to maintain continuity of supply and preserve development timelines under the altered trade environment.

Actionable segmentation-driven insight that ties product type, application focus, cell lineage, and packaging mode to procurement and validation priorities

A clear understanding of product and application segmentation is essential to align product development and procurement priorities with end-use requirements. Based on Product Type, market is studied across 2D Bags and 3D Bags, which delineates devices optimized for traditional planar processes and those engineered for advanced volumetric or scaffold-based culture respectively. Based on Application, market is studied across Biopharmaceutical Production and Research & Development. The Biopharmaceutical Production is further studied across Monoclonal Antibody Production, Recombinant Protein Production, and Vaccine Production. The Research & Development is further studied across Bioprocess Development, Monoclonal Antibody Research, and Stem Cell Research, a segmentation that clarifies how end-users prioritize attributes such as sterility assurance, scalability, and material compatibility depending on their process stage.

Based on Cell Type, market is studied across Insect and Mammalian. The Mammalian is further studied across CHO, Hybridoma, and NS0, and this distinction underscores the different biochemical and physical demands that each cell lineage places on media formulation and container materials. Based on Packaging Mode, market is studied across Bulk Bags and Single-Use Pre-Filled Bags, highlighting the operational trade-offs between centralized dispensing efficiency and convenience of pre-filled, ready-to-use formats. These segmentation pillars provide a framework for evaluating how product design and supplier services must adapt to meet specific performance, handling, and regulatory documentation requirements.

Interpreting commercial and technical decisions through these segmentation lenses enables more precise product alignment with process needs. It also supports targeted validation efforts by clarifying which attributes require prioritized testing for a given product-application-cell type-packaging combination. Consequently, product roadmaps and procurement specifications that incorporate these dimensions are better able to anticipate user pain points and to deliver solutions that integrate seamlessly with established workflows.

Regional dynamics and regulatory nuances that shape supplier qualification, inventory strategy, and operational continuity across global biomanufacturing hubs

Geography continues to shape strategic priorities, supplier selection, and regulatory engagement in the cell culture media bags space. In the Americas, investments in advanced biologics development and contract manufacturing capacity have driven demand for validated, scalable single-use systems; organizations in this region often emphasize rapid time-to-clinic and integrated supplier services. Conversely, Europe, Middle East & Africa presents a complex regulatory tapestry and a strong emphasis on compliance documentation and standardized quality systems, prompting suppliers to offer enhanced technical dossiers and region-specific regulatory support.

Asia-Pacific combines rapid capacity expansion with diverse manufacturing capabilities, where local production hubs and regional partnerships reduce lead times and offer cost advantages while also requiring nimble approaches to local certification and materials sourcing. Across these regions, differences in supplier ecosystems influence how companies structure sourcing strategies and invest in supplier qualification. The balance between centralized global procurement and regional qualification varies by organizational appetite for logistical complexity and the need for close regulatory alignment.

Understanding regional distinctions informs decisions about where to qualify alternative suppliers, how to tailor documentation for regulatory submissions, and what inventory strategies will most effectively mitigate logistical risk. Companies that align their supplier engagement and qualification timelines with these regional realities are better equipped to maintain continuity of operations and to accelerate development and manufacturing milestones across diverse geographies.

How supplier transparency, materials expertise, and integrated service models are creating competitive differentiation in single-use media delivery solutions

Leading suppliers in the cell culture media bags ecosystem are increasingly differentiating through a combination of technical documentation, materials science expertise, and integrated service offerings. Firms that invest in comprehensive extractables and leachables testing, compatibility matrices, and robust supply chain traceability gain distinct advantages when engaging with regulated manufacturers and contract organizations. These capabilities reduce downstream validation burden for customers and support faster uptake in production-critical applications.

In parallel, companies that provide configuration flexibility-such as multiple connector types, sterilization options, and pre-filled versus bulk packaging modalities-are better placed to serve a wider swath of end users. Strategic partnerships with materials suppliers and contract assemblers further strengthen vendor value propositions by enabling localized manufacturing and quicker response to specification changes. Additionally, suppliers that offer consultative support during process transfer and scale-up stages build deeper customer relationships and reduce friction during qualification cycles.

Competitive positioning increasingly hinges on transparency and collaboration. Vendors that publish detailed technical data, offer sample evaluation programs, and participate in cross-functional validation activities earn trust and facilitate adoption. For organizations procuring media delivery systems, prioritizing suppliers that combine rigorous science with flexible service models delivers tangible operational benefits and helps to future-proof bioprocess workflows.

Practical, high-impact recommendations to strengthen supplier resilience, validation efficiency, and operational agility for users of media delivery systems

Industry leaders should adopt a pragmatic program that balances immediate operational resilience with strategic capability building. First, prioritize diversification of qualified suppliers across different regions to reduce exposure to single points of failure; aligning supplier qualification timelines with regional regulatory expectations will accelerate parallel sourcing without inducing rework. Second, invest in deep technical due diligence that focuses on extractables and leachables profiles, material compatibility, and connector interoperability to minimize surprises during process transfer and scale-up.

Third, enhance inventory and procurement practices by aligning safety stock policies with product shelf-life and sterilization logistics; this reduces the risk of production interruptions while avoiding excessive storage costs. Fourth, cultivate collaborative relationships with suppliers that can provide localized assembly or filling to shorten lead times and simplify customs processes. Fifth, integrate procurement, quality, and process development teams early in supplier selection to ensure that technical validation and operational readiness proceed in parallel rather than in sequence.

Finally, pursue controlled pilot implementations of new bag formats in less critical production runs to validate handling, integration, and performance under real-world conditions before widespread deployment. These combined actions will strengthen supply resilience, improve time-to-deployment for new formats, and preserve the flexibility necessary to respond to evolving product and regulatory challenges.

A rigorous mixed-methods research approach combining technical interviews, materials evaluation, and supplier documentation cross-validation to inform practical decisions

The research approach underlying this report combines primary interviews with technical and procurement leaders, exhaustive review of materials science literature, and cross-validation of supplier technical documentation to ensure robustness of insights. Primary data collection included structured interviews with process development scientists, quality assurance leads, and procurement specialists to capture real-world constraints and priorities associated with container selection and qualification. This qualitative evidence was complemented by detailed analysis of publicly available technical reports and regulatory guidance documents to validate testing and documentation practices.

Materials compatibility and extractables and leachables evaluations were reviewed against industry best practices and regulatory expectations to assess common qualification pathways. Supplier service models and regional manufacturing footprints were examined through company filings and technical white papers to understand operational capabilities and logistical implications. Wherever possible, observations were triangulated across multiple sources to reduce bias and to emphasize reproducible operational lessons.

The methodology prioritizes actionable findings over abstract metrics, focusing on the implications of technology choices for validation timelines, supply chain risk, and process control. Limitations are acknowledged where proprietary data or emerging product evaluations constrain conclusive generalizations; in such cases, recommended follow-up activities are provided to guide targeted investigations and vendor trials.

A focused conclusion emphasizing the integrated importance of technical validation, supplier transparency, and supply chain resilience in decision-making

In sum, advancements in bag design, materials science, and regulatory expectations are collectively reshaping how organizations select and qualify media delivery systems. The interplay between technical performance, documentation rigor, and supply chain configuration now determines operational readiness as much as product specifications do. As a result, procurement decisions must be informed by a holistic view that includes compatibility testing, supplier transparency, regional qualification considerations, and contingency planning.

Organizations that proactively integrate technical assessment with strategic sourcing stand to reduce validation friction and improve continuity during scale-up. Similarly, vendors that prioritize scientific rigor, flexible configurations, and strong regional support are best positioned to meet the evolving needs of biologics developers and manufacturers. Moving forward, sustained focus on collaborative qualification practices and adaptable supply relationships will be essential to maintaining robust, reproducible processes across diverse applications and cell types.

Decision-makers should therefore treat media delivery system selection as a multi-dimensional choice that impacts development timelines, product quality controls, and operational resilience. By aligning procurement, quality, and process development around shared criteria and by engaging in early supplier collaboration, organizations can mitigate risk and accelerate the translation of lab-scale processes into reliable production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Culture Media Bags Market, by Product Type

  • 8.1. 2D Bags
  • 8.2. 3D Bags

9. Cell Culture Media Bags Market, by Cell Type

  • 9.1. Insect
  • 9.2. Mammalian
    • 9.2.1. CHO
    • 9.2.2. Hybridoma
    • 9.2.3. NS0

10. Cell Culture Media Bags Market, by Packaging Mode

  • 10.1. Bulk Bags
  • 10.2. Single-Use Pre-Filled Bags

11. Cell Culture Media Bags Market, by Application

  • 11.1. Biopharmaceutical Production
    • 11.1.1. Monoclonal Antibody Production
    • 11.1.2. Recombinant Protein Production
    • 11.1.3. Vaccine Production
  • 11.2. Research & Development
    • 11.2.1. Bioprocess Development
    • 11.2.2. Monoclonal Antibody Research
    • 11.2.3. Stem Cell Research

12. Cell Culture Media Bags Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Cell Culture Media Bags Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Cell Culture Media Bags Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Cell Culture Media Bags Market

16. China Cell Culture Media Bags Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avantor, Inc.
  • 17.6. BIOPAC
  • 17.7. CellBios Healthcare & Lifesciences Pvt Ltd
  • 17.8. Corning Incorporated
  • 17.9. Danaher Corporation
  • 17.10. Entegris, Inc.
  • 17.11. Eppendorf AG
  • 17.12. FUJIMORI KOGYO Co., Ltd.
  • 17.13. Greiner Bio-One International GmbH
  • 17.14. Lonza Group AG
  • 17.15. Meissner Filtration Products, Inc.
  • 17.16. Merck KGaA
  • 17.17. OriGen Biomedical, Inc.
  • 17.18. Parker Hannifin Corporation
  • 17.19. PBS Biotech, LLC
  • 17.20. Repligen Corporation
  • 17.21. Saint-Gobain Life Sciences
  • 17.22. Sartorius AG
  • 17.23. Thermo Fisher Scientific, Inc.
  • 17.24. Tofflon Life Science Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL CULTURE MEDIA BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CELL CULTURE MEDIA BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 2D BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY 3D BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY CHO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY HYBRIDOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY NS0, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BULK BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY SINGLE-USE PRE-FILLED BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RECOMBINANT PROTEIN PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY MONOCLONAL ANTIBODY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 134. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 138. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 139. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 158. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 162. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 163. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 170. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 171. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CELL CULTURE MEDIA BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY CELL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY PACKAGING MODE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA CELL CULTURE MEDIA BAGS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)